American Regent, Inc.

This study tested a modified version of a chemotherapy drug called Taxoprexin for people with advanced liver, gallbladder, or bile duct cancer that had worsened after their first treatment. The goal was to see if the weekly drug infusions could shrink tumors, control the disease,…